The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes & centers will be combined into eight (with only NCI, NIA & NIAID retaining their original structure). There are 40% cuts proposed in NIH budget (including the NCI). 😢 Cancer Research 📉

Lab scientists are now resorting to "Go fund me" like campaigns to keep their labs afloat (and not fire personnel). Just awful (but do consider helping them out!).

NIH is temporarily extending eligibility for some mentored career development awards. If your award prematurely ended on/after Jan. 1, 2025, you can apply for a new mentored career development award if all other requirements are met. grants.nih.gov/news-events/ni…

Clinicians and scientists, please consider attending this webinar and/or passing along this webinar information to your patients. We need more advocates than ever before. #researchmatters #advocacyinaction

📢 Save the Date! The IASLC 2025 Hot Topic Meeting is coming to Tokyo, Nov 21–23! 🧬 Focus: Early lung carcinogenesis, emerging biomarkers & new therapeutic targets. Join leading researchers, clinicians & oncology experts. 🔗 bit.ly/25FallHT #HT25 #IASLC #LungCancer

The Curated Cancer Cell Atlas provides a comprehensive characterization of tumors at single-cell resolution nature.com/articles/s4301…

Patrick Paddison and friends lighting it up!

In our visitor center, guests can leave behind notes about their reasons for being here. Many are tributes to the fathers in our lives. To every dad — whether you're working in the lab or clinic, receiving care, or living on in our memories — thank you. Happy #FathersDay!

Passing by Fred Hutch this afternoon.

Important awareness piece by BBC News (UK) reminding us that lung cancer is on the rise in people who have never smoked. These are different types of lung cancer and we’re still learning why they occur: radon, pollution, unknown. All of us are at risk. bbc.com/future/article…

EGFR+ #LungCancer investigators: RFP is available for a new $1.5M Team Science award, made possible by a generous private donation from Benay and Steven Taub. LOIs due July 29: LCRF.org/funding

Funding lung cancer research benefits everyone with lungs. #LungCancerResearch #LungCancerAwareness #ResearchFunding bit.ly/2m5l8Kc

Now in Cancer Cell our group reports the development of a first-in-class EGFR-directed KRAS G12V selective inhibitor. KRAS G12V mutations are the 2nd most common KRAS mutation in cancer, and there are still no approved inhibitors in the clinic. We address two major challenges

Hello RNA World! Ever wonder what's "talking to" your favorite transcript, but were too scared to ask? In our review in Cell Reports, Faraz K Mardakheh and I highlight new RNA-focused tools for discovering RNA interactions across organizational scales. Checkit! tinyurl.com/ydn6e3ac

🚨 Survival of pts with Lung Adenocarcinoma diagnosed in 2000, 2010, and 2020. 📊 Median OS in lung adenocarcinoma more than doubled in 20 years (8.5 → 20.7 months) in non-academic public hospitals in 🇫🇷. 🔹 Targeted therapy and immunotherapy significantly improved outcomes,

During his 36-year career at Fred Hutch/Hutch Basic Sciences, Michael Emerman, PhD, made fundamental discoveries about HIV, co-founded the field of paleovirology and mentored generations of scientists. bit.ly/4nMqOmr

Lilly: The culmination of decades of research, failed attempts, and countless billions of dollars gave us a cure for some of the most prominent and pernicious diseases. Sales: ~$15 billion Response: Drugs/Pharma are evil, kill the CEO, you are a bad person for using drugs.

Have $10M and want to cure some diseases? It costs ~$1B to invent a new medicine…but $10M buys you Project Encore, to see if ANY existing drug might be repurposed for ~100 diseases that have no treatments. Contact me - be a hero for desperate patients! docs.google.com/document/d/1dM…

Post Doctoral program of Pfizer Inc. It provides a unique opportunity to pursue ground-breaking research in the areas of disease biology, drug delivery, mechanisms of action, and cutting-edge computation and informatics for a period of 2-4 years. Details at pfizer.com/en/about/caree…

Join us in at Moffitt! The Metabolism Program is recruiting at the Assistant Member (Assistant Professor) level. Review of applications starts September 1st. Please share! Details here: …cancer-center-careers.hctsportals.com/jobs/1883440-t…